Approval · Notice of Compliance 17443 · 2015
CINRYZE: Notice of Compliance 17443
Issued October 30, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17443
- Date
- October 30, 2015
- Company
- Viropharma Biologics Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CINRYZE | Not yet assigned | — |
Medicinal ingredients
- C1 ESTERASE INHIBITOR (HUMAN) 500 UNIT per VIAL